Back to Search Start Over

Invasive hepatic mucormycosis: A case report and review of the literature.

Authors :
Karigane D
Kikuchi T
Sakurai M
Kato J
Yamane Y
Hashida R
Abe R
Hatano M
Hasegawa N
Wakayama M
Shibuya K
Okamoto S
Mori T
Source :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2019 Jan; Vol. 25 (1), pp. 50-53. Date of Electronic Publication: 2018 Jul 26.
Publication Year :
2019

Abstract

Mucormycosis generally develops under immunocompromised conditions, including hematological malignancies and solid organ or hematopoietic stem cell transplantation. Although mucormycosis usually affects the lungs and paranasal sinuses, sporadic cases of invasive mucormycosis of the liver have been reported. We hereby report a patient with myelofibrosis who developed hepatic mucormycosis diagnosed by post-mortem examination. An extensive literature review identified 13 reported cases of hepatic mucormycosis, including ours, without lung involvement. Most of the underlying diseases or conditions were hematological malignancies and solid organ transplantation. Three cases had splenic lesions and four had gastrointestinal lesions, suggesting the possibility of translocation to the liver and/or spleen from the gastrointestinal tracts. Hepatic mucormycosis should be recognized as one of the presentations of invasive mucormycosis, especially when hepatic nodules are found in immunocompromised patients such as those with hematological malignancy or recipients of solid organ transplantation.<br /> (Copyright © 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1437-7780
Volume :
25
Issue :
1
Database :
MEDLINE
Journal :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Publication Type :
Academic Journal
Accession number :
30057341
Full Text :
https://doi.org/10.1016/j.jiac.2018.06.013